Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1957 3
1958 1
1960 1
1961 3
1962 6
1963 1
1964 10
1965 6
1966 6
1967 13
1968 10
1969 9
1970 27
1971 35
1972 27
1973 48
1974 30
1975 68
1976 58
1977 30
1978 39
1979 40
1980 45
1981 60
1982 71
1983 85
1984 88
1985 132
1986 111
1987 98
1988 115
1989 127
1990 131
1991 137
1992 147
1993 153
1994 157
1995 158
1996 158
1997 183
1998 190
1999 225
2000 255
2001 305
2002 344
2003 359
2004 362
2005 423
2006 456
2007 459
2008 494
2009 584
2010 610
2011 732
2012 745
2013 739
2014 803
2015 749
2016 827
2017 793
2018 820
2019 836
2020 1008
2021 929
2022 800
2023 705
2024 257

Text availability

Article attribute

Article type

Publication date

Search Results

16,615 results

Results by year

Filters applied: . Clear all
Page 1
Herpes zoster: A Review of Clinical Manifestations and Management.
Patil A, Goldust M, Wollina U. Patil A, et al. Viruses. 2022 Jan 19;14(2):192. doi: 10.3390/v14020192. Viruses. 2022. PMID: 35215786 Free PMC article. Review.
In children and youngsters, HZ is rare and associated to metabolic and neoplastic disorders. In adults, advanced age, distress, other infections (such as AIDS or COVID-19), and immunosuppression are the most common risk factors. HZ reactivation has recently been obs …
In children and youngsters, HZ is rare and associated to metabolic and neoplastic disorders. In adults, advanced age, distress, other …
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation.
Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, Humar A; The Transplantation Society International CMV Consensus Group. Kotton CN, et al. Transplantation. 2018 Jun;102(6):900-931. doi: 10.1097/TP.0000000000002191. Transplantation. 2018. PMID: 29596116 Free article. Review.
Highlights include advances in molecular and immunologic diagnostics, improved understanding of diagnostic thresholds, optimized methods of prevention, advances in the use of novel antiviral therapies and certain immunosuppressive agents, and more savvy appro …
Highlights include advances in molecular and immunologic diagnostics, improved understanding of diagnostic thresholds, optimized methods of …
Aspergillosis: Epidemiology, Diagnosis, and Treatment.
Cadena J, Thompson GR 3rd, Patterson TF. Cadena J, et al. Infect Dis Clin North Am. 2021 Jun;35(2):415-434. doi: 10.1016/j.idc.2021.03.008. Infect Dis Clin North Am. 2021. PMID: 34016284 Review.
Invasive aspergillosis is a major cause of morbidity and mortality in immunocompromised patients. Risk factors continue to evolve and include newer biological agents that target the immune system and postinfluenza infection; and it has been observed following …
Invasive aspergillosis is a major cause of morbidity and mortality in immunocompromised patients. Risk factors continue to evolve and …
Systemic lupus erythematosus: Diagnosis and clinical management.
Fava A, Petri M. Fava A, et al. J Autoimmun. 2019 Jan;96:1-13. doi: 10.1016/j.jaut.2018.11.001. Epub 2018 Nov 16. J Autoimmun. 2019. PMID: 30448290 Free PMC article. Review.
Use of immunomodulators and immunosuppression has altered the natural course of SLE. In addition, morbidity and mortality in SLE not only derive from direct immune mediated tissue damage but also from SLE and treatment associated complications such as accelerated co …
Use of immunomodulators and immunosuppression has altered the natural course of SLE. In addition, morbidity and mortality in SLE not …
Lupus nephritis: new progress in diagnosis and treatment.
Yu C, Li P, Dang X, Zhang X, Mao Y, Chen X. Yu C, et al. J Autoimmun. 2022 Oct;132:102871. doi: 10.1016/j.jaut.2022.102871. Epub 2022 Aug 20. J Autoimmun. 2022. PMID: 35999111 Review.
Up to now, the complete remission rate of LN is only 20%30% after receiving six months of standard treatment, which is far from satisfactory. Moreover, adverse reactions to immunosuppressants, especially glucocorticoids, further compromise the prognosis of LN. ...The Europ …
Up to now, the complete remission rate of LN is only 20%30% after receiving six months of standard treatment, which is far from satisfactory …
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.
Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA; National Comprehensive Cancer Network. Brahmer JR, et al. J Clin Oncol. 2018 Jun 10;36(17):1714-1768. doi: 10.1200/JCO.2017.77.6385. Epub 2018 Feb 14. J Clin Oncol. 2018. PMID: 29442540 Free PMC article.
Purpose To increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy. ...ICPi therapy may be suspended for most grade 2 …
Purpose To increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events …
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.
Penack O, Marchetti M, Ruutu T, Aljurf M, Bacigalupo A, Bonifazi F, Ciceri F, Cornelissen J, Malladi R, Duarte RF, Giebel S, Greinix H, Holler E, Lawitschka A, Mielke S, Mohty M, Arat M, Nagler A, Passweg J, Schoemans H, Socié G, Solano C, Vrhovac R, Zeiser R, Kröger N, Basak GW. Penack O, et al. Lancet Haematol. 2020 Feb;7(2):e157-e167. doi: 10.1016/S2352-3026(19)30256-X. Lancet Haematol. 2020. PMID: 32004485 Review.
Graft-versus-host disease (GVHD) is a major factor contributing to mortality and morbidity after allogeneic stem-cell transplantation. ...
Graft-versus-host disease (GVHD) is a major factor contributing to mortality and morbidity after allogeneic stem-cell transpla …
Pulmonary aspergillosis: diagnosis and treatment.
Lamoth F, Calandra T. Lamoth F, et al. Eur Respir Rev. 2022 Nov 29;31(166):220114. doi: 10.1183/16000617.0114-2022. Print 2022 Dec 31. Eur Respir Rev. 2022. PMID: 36450372 Free PMC article.
Aspergillus species are the most frequent cause of fungal infections of the lungs with a broad spectrum of clinical presentations including invasive pulmonary aspergillosis (IPA) and chronic pulmonary aspergillosis (CPA). IPA affects immunocompromised populations, which ar …
Aspergillus species are the most frequent cause of fungal infections of the lungs with a broad spectrum of clinical presentations including …
Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies.
Ramirez JA, Musher DM, Evans SE, Dela Cruz C, Crothers KA, Hage CA, Aliberti S, Anzueto A, Arancibia F, Arnold F, Azoulay E, Blasi F, Bordon J, Burdette S, Cao B, Cavallazzi R, Chalmers J, Charles P, Chastre J, Claessens YE, Dean N, Duval X, Fartoukh M, Feldman C, File T, Froes F, Furmanek S, Gnoni M, Lopardo G, Luna C, Maruyama T, Menendez R, Metersky M, Mildvan D, Mortensen E, Niederman MS, Pletz M, Rello J, Restrepo MI, Shindo Y, Torres A, Waterer G, Webb B, Welte T, Witzenrath M, Wunderink R. Ramirez JA, et al. Chest. 2020 Nov;158(5):1896-1911. doi: 10.1016/j.chest.2020.05.598. Epub 2020 Jun 16. Chest. 2020. PMID: 32561442 Free PMC article. Review.
BACKGROUND: Community-acquired pneumonia (CAP) guidelines have improved the treatment and outcomes of patients with CAP, primarily by standardization of initial empirical therapy. But current society-published guidelines exclude immunocompromised patients. ...The pa …
BACKGROUND: Community-acquired pneumonia (CAP) guidelines have improved the treatment and outcomes of patients with CAP, primarily by standa …
Diagnosis and Treatment of Aplastic Anemia.
Peslak SA, Olson T, Babushok DV. Peslak SA, et al. Curr Treat Options Oncol. 2017 Nov 16;18(12):70. doi: 10.1007/s11864-017-0511-z. Curr Treat Options Oncol. 2017. PMID: 29143887 Free PMC article. Review.
Diagnosis of AA requires a comprehensive approach with prompt evaluation for inherited and secondary causes of bone marrow aplasia, while providing aggressive supportive care. The choice of frontline therapy is determined by a number of factors including AA severity …
Diagnosis of AA requires a comprehensive approach with prompt evaluation for inherited and secondary causes of bone marrow aplasia, while pr …
16,615 results
You have reached the last available page of results. Please see the User Guide for more information.